000 01036 a2200253 4500
005 20250516012804.0
264 0 _c20111003
008 201110s 0 0 eng d
022 _a1432-1459
024 7 _a10.1007/s00415-010-5718-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMiyasaki, Janis M
245 0 0 _aEvidence-based initiation of dopaminergic therapy in Parkinson's disease.
_h[electronic resource]
260 _bJournal of neurology
_cNov 2010
300 _aS309-13 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
650 0 4 _aDopamine Agents
_xadministration & dosage
650 0 4 _aDyskinesia, Drug-Induced
_xprevention & control
650 0 4 _aEvidence-Based Medicine
_xstandards
650 0 4 _aHumans
650 0 4 _aParkinson Disease
_xdiagnosis
773 0 _tJournal of neurology
_gvol. 257
_gno. Suppl 2
_gp. S309-13
856 4 0 _uhttps://doi.org/10.1007/s00415-010-5718-x
_zAvailable from publisher's website
999 _c20377464
_d20377464